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A commentary on
Sudden Cardiac Risk Stratification with Electrocardiographic Indices - A Review on
Computational Processing, Technology Transfer, and Scientific Evidence
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Alvarez, J. L. (2016). Front. Physiol. 7:82. doi: 10.3389/phys.2016.00082
I read with interest the excellent article on sudden cardiac death risk stratification with
electrocardiographic (ECG) indices by Dr. Gimeno-Blanes and his colleagues in the recent issue
of Frontiers in Physiology (Gimeno-Blanes et al., 2016). The article is unique in that it included
computational processing, technology transfer, and scientific evidence, critical considerations in
the long and challenging path from bench to bedside. The parameters discussed, namely heart rate
variability, heart rate turbulence, and microvolt T-wave alternans (TWA), are well-considered as
they are the most extensively studied contemporary ECG-based risk stratification parameters.
In this commentary, I would like to register some additional considerations with respect to
time-domain analysis of microvolt TWA using the Modified Moving Average (MMA) method. We
have studied this parameter in our laboratory for more than two decades. The MMAmethodology
has run the complete gambit from development through clearance by the United States FDA and a
recent positive coverage decision by Center for Medicare andMedicaid Services (https://www.cms.
gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=275). As the authors
pointed out, it differs from the spectral method and while there are commonalities, there are
critical differences in the approach and in the clinical evidence supporting the two methods.
The MMA method employs the noise-rejection principle of recursive averaging. The algorithm
continuously streams odd and even beats into separate bins and creates averaged complexes
for each bin. These complexes are then superimposed, and the maximum difference between
the odd and even complexes at any point within the JT segment is identified for every 15 s
and reported as the TWA value. The highest TWA levels within the entire 24-h period are
recorded for each subject and used for analysis of risk for sudden cardiac death or cardiovascular
Verrier Commentary: Sudden Cardiac Risk Stratification
FIGURE 1 | Precordial (V4) electrocardiogram rhythm strip (left panel) and high-resolution template of QRS-aligned complexes (right panel) during
routine exercise testing from a patient with coronary artery disease who experienced cardiovascular death at 12 months following the recording. The
template illustrates T-wave alternans (TWA) as a separation between ST-T segments in A and B beats. mV, millivolt; sec, second. Reproduced with permission from
Verrier et al. (2011).
mortality. The established TWA cut-point of 47 µV indicates
a positive TWA test. Inspection of the TWA template permits
verification of the waveform and provides opportunities for
insights into the pathophysiology, as distinct patterns are
associated with differing disease states. Samples of the rhythm
strip and QRS-aligned template are provided (Figure 1; Verrier
et al., 2011).
The experience with the MMA method includes ∼1800
patients studied with ambulatory ECG monitoring (Verrier
and Malik, 2015). An additional ∼3600 patients were studied
during routine exercise testing in the FINnish CArdioVAscular
Study, the largest single study with any ECG-based risk stratifier
(Verrier et al., 2011). Worldwide populations have been enrolled
in MMA-based studies, including in Europe, Asia, and North
and South America. When the method commercialized by
GE Healthcare was employed, there were no non-predictive
studies. The cutpoints have been standardized, with 47 µV being
abnormal and 60 µV severely abnormal (Verrier et al., 2011).
A critical factor is that the TWA testing by both the
Spectral and MMA methods needs to be performed on
chronic medications, especially beta-adrenergic blockers, as
recommended by 11 expert authors of the TWA consensus
guideline (Verrier et al., 2011, p. 1321). The reason for this
recommendation is that these agents affect arrhythmia risk and
TWA levels in parallel. The approach of washing out beta-
blockers was developed to allow patients tested with the spectral
method to achieve the required target heart rate of 105 to 110
beats/min during exercise and is likely to have been a factor
in the high-visibility negative MASTER Study and SCD-HeFT
TWA substudy (Verrier et al., 2011). When beta-blocking agents
were washed out for the test and subsequently resumed, hazard
ratio were reduced to one quarter. As the MMA method does
not require meeting a target heart rate, washout of medications
is unnecessary; this factor may help to account in part for the
absence of negative studies.
It can be argued that because TWA is predictive in
patient on medications, it is capable of predicting the effects
of medications. This principle may be applicable to the
> 12,000 patients in whom TWA has been measured
who were receiving antiarrhythmic therapy, as they were
drawn from cohorts with diverse forms of coronary artery
disease including myocardial ischemia and heart failure. The
potential of TWA to guide medical therapy as well as
exercise rehabilitation has been recently reviewed (Verrier and
Malik, 2015). Quantitative analysis is an essential element
in guiding therapy, as only when the level of TWA is
designated in microvolts can the effects of therapy be
assessed.
The authors made some major points that apply not only
to TWA testing but to other ECG-based parameters, especially
the need to obtain more longitudinal information. The basic
physiology and pathophysiology of myocardial substrate and
autonomic influences are dynamic, with day-to-day variations
and changes in disease state. A prime example is the
period following acute myocardial infarction, as considerable
remodeling occurs in the ensuing 90 days. For this reason,
it has been recommended that risk stratification for long-
term prediction be performed only at 10 to 14 weeks after
the event. However, it can also be argued that the immediate
followup period should not be ignored, particularly in patients
with depressed ejection fraction, who are at high risk of
dying suddenly in this early period. New possibilities are
evolving with advances in telemonitoring, in which ECG
patches and smartphone based technologies can be applied
(Fung et al., 2015). Thus, more extensive data acquisition with
contemporary parameters can help to fill in the ECG-based
picture of risk.
While the question can be debated about whether or not
quantitative TWA analysis with the MMA method is in prime
time, there is considerable evidence that it deserves a position on
stage.
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